Although neither IL-6 mRNA levels in tumor tissues nor basal serum IL-6 levels correlated with sensitivity to radiotherapy in esophageal cancer patients, the percentage increase in serum IL-6 levels after radiotherapy was inversely correlated with tumor regression. This evidence concerns the gene IL6 and neoplasm.